Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression
Activation of the tyrosine kinase c-Src promotes breast cancer progression and poor outcomes, yet the underlying mechanisms are incompletely understood. Here, we have shown that deletion of c-Src in a genetically engineered model mimicking the luminal B molecular subtype of breast cancer abrogated t...
Main Authors: | Ipshita Nandi, Harvey W. Smith, Virginie Sanguin-Gendreau, Linjia Ji, Alain Pacis, Vasilios Papavasiliou, Dongmei Zuo, Stella Nam, Sherif S. Attalla, Sung Hoon Kim, Sierra Lusson, Hellen Kuasne, Anne-Marie Fortier, Paul Savage, Constanza Martinez Ramirez, Morag Park, John A. Katzenellenbogen, Benita S. Katzenellenbogen, William J. Muller |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2023-04-01
|
Series: | The Journal of Clinical Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1172/JCI162324 |
Similar Items
-
Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer
by: Benita S. Katzenellenbogen, et al.
Published: (2023-06-01) -
Transcription Regulation and Genome Rewiring Governing Sensitivity and Resistance to FOXM1 Inhibition in Breast Cancer
by: Yvonne Ziegler, et al.
Published: (2021-12-01) -
Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer
by: Parama Dey, et al.
Published: (2020-09-01) -
An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis
by: Harvey W. Smith, et al.
Published: (2019-07-01) -
Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
by: Zeynep Madak‐Erdogan, et al.
Published: (2017-04-01)